|Articles|June 1, 2016
Scaling-Up from Lab to Commercial Scale
Advertisement
Nicolle Courtemanche, senior applications engineer at SPX Flow, sat down with Biopharm International to discuss scale up from lab to commercial scale.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
How Engineered Exosomes Can Impact Targeted Therapies
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
